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Drug-resistant temporal lobe epilepsy (TLE) and epileptic syndromes related to malfor-
mations of cortical development (MCD) are associated with complex hippocampal mor-
phology.The contribution of volume and position to the overall hippocampal shape in these
conditions has not been studied.We propose a surface-based framework to localize volume
changes through measurement of Jacobian determinants, and quantify fine-scale position
and curvature through a medial axis model. We applied our methodology to T1-weighted
3D volumetric MRI of 88 patients with TLE and 78 patients with MCD, including focal cor-
tical dysplasia (FCD, n=29), heterotopia (HET, n=40), and polymicrogyria (PMG, n=19).
Patients were compared to 46 age- and sex-matched healthy controls. Surface-based analy-
sis of volume inTLE revealed severe ipsilateral atrophy mainly along the rostro-caudal extent
of the hippocampal CA1 subfield. In MCD, patterns of volume changes included bilateral
CA1 atrophy in HET and FCD, and left dentate hypertrophy in all three groups.The analysis
of curvature revealed medial bending of the posterior hippocampus in TLE, whereas in
MCD there was a supero-medial shift of the hippocampal body. Albeit hippocampal shape
anomalies in TLE and MCD result from a combination of volume and positional changes,
their nature and distribution suggest different pathogenic mechanisms.
Keywords: temporal lobe epilepsy, malformations of cortical development, hippocampus, image analysis, shape
analysis
INTRODUCTION
Growing evidence suggests that abnormalities of brain develop-
ment are etiological factors contributing to epilepsy. In particular,
syndromes in which pathogenic mechanisms involve the temporal
lobe may be associated with abnormal hippocampal morphology,
identified as atypical shape and positioning. These macroscopic
markers of brain maldevelopment, referred to as malrotation, have
been reported in high proportions of patients with temporal lobe
epilepsy (TLE) and those with malformation of cortical develop-
ment (MCD) (1–7). Such anomalies may be found in about 10%
of healthy controls, and are believed to represent the end of phe-
notypic spectrum of a normal hippocampal formation (3, 8). In
our previous work, we created quantitative models of hippocam-
pal malrotation based on their MRI characteristics (7, 8). These
empirically defined models were designed to assess at a global scale
hippocampal shifting and rotation with respect to its long axis,
and thus only partially captured the complexity of hippocampal
morphology.
In this work, we aimed at assessing independently the con-
tribution of volume and position to the overall hippocampal
shape in TLE and MCD. To this purpose, we applied our previ-
ously developed and validated methods (9, 10), based on spherical
harmonic shape descriptors. Our data-driven approach local-
ized variations of volume at a sub-millimetric level through
the analysis of Jacobian determinants, and quantified fine-
scale local position and curvature through a medial axis
model.
MATERIALS AND METHODS
SUBJECTS
From our database of patients referred for the investigation of
drug-resistant epilepsy, we selected patients with MCD (n= 88;
39 males; mean age: 31± 9, range: 18–58) and those with TLE
(n= 78; 34 males; mean age: 36± 10, range: 17–57) who had been
examined with the same MRI scanner and in whom hippocampal
volumetry was performed. Patients in whom the cortical develop-
mental malformation invaded the hippocampus were excluded.
No TLE patient had a mass lesion (tumor, vascular malforma-
tion) or traumatic brain injury. The MCD population included
patients with focal cortical dysplasia (n= 29; 11 males; mean age:
30± 9), heterotopia (n= 40; 19 males; mean age: 31± 10), and
polymicrogyria (n= 19; 9 males; mean age: 32± 8). Focal cortical
dysplasia was located outside the temporal lobe in all patients. The
heterotopia group included patients with double cortex (n= 11),
periventricular nodular heterotopia (n= 26; bilateral in 13, unilat-
eral in 13), and unilateral subcortical heterotopia (n= 3). Lesions
of polymicrogyria were bilateral in 16/19 patients (perisylvian
in 12, other combinations in 4), and unilateral perisylvian in
3/19.
Demographic and clinical data were obtained through inter-
views with the patients and their relatives. The diagnosis and
localization of the seizure focus was based on a standard clinical
evaluation including detailed history, seizure semiology, neuro-
logical examination, video-EEG recordings, and MRI evaluation
in all patients.
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In TLE, the seizure focus was left-sided in 34 patients and right-
sided in 44. Sixty-seven patients underwent surgery. Mean± SD
follow-up time was 3.6± 3.2 years. We determined post-surgical
seizure outcome according to Engel’s modified classification (11)
51 (76%) patients had Class I outcome, 5 (8%) Class II, 7 (10%)
Class III, and 4 (6%) Class IV. In MCD patients, the seizure focus
was frontal in 15 patients,parietal in 7, temporal in 21,and multilo-
bar or generalized in 37. Five patients presented only with interictal
slow activity and three patients had a normal EEG.
The control group consisted of 46 age- and sex-matched (23
males; mean age: 32± 12 years, range: 20–56) healthy individuals.
The Ethics Committee of the Montreal Neurological Institute and
Hospital approved the study and written informed consent was
obtained from all participants.
MRI ACQUISITION AND PRE-PROCESSING
Images were acquired on a 1.5T Gyroscan (Philips Medical Sys-
tems, Eindhoven, Netherlands) using a 3D T1-fast field echo
sequence (TR= 18 ms; TE= 10 ms; NEX= 1; flip angle= 30°;
matrix size= 256× 256; FOV= 256 mm; slice thickness= 1 mm),
providing an isotropic voxel volume of 1 mm3. Prior to pro-
cessing, images underwent automated correction for intensity
non-uniformity and intensity standardization (12).
The hippocampus was segmented manually according to our
previously published protocol (13). Prior to segmentation, MR
images were registered into the MNI ICBM-152 template (14)
using nine parameter linear transformation (15). Hippocampal
volumes were normalized through a z-transformation relative to
the corresponding distribution of healthy controls.
SURFACE-BASED ANALYSIS OF VOLUME
Hippocampal labels were converted to surface meshes and para-
meterized using spherical harmonics with point distribution
model (SPHARM-PDM) (16). The SPHARM-PDM surfaces of
each individual were rigidly aligned to a hippocampal template
(constructed from the mean surface of controls and patients)
using their centroid and the longitudinal axis of the first order
ellipsoid (17). To correct for differences in overall head size, each
surface was inversely scaled with respect to intra-cranial volume
(16). We calculated displacement vectors between each subject’s
SPHARM-PDM surface and the template across 1,002 vertices
(16). The signed surface normal components of these vectors
quantify inward/outward deformations. To compute vertex-wise
volume changes, we applied the heat equation to interpolate the
vertex-wise displacement vectors within the volume enclosed by
the SPHARM-PDM surface (9). The Jacobian determinant J of
the resulting dense vector field was projected back onto the sur-
face to quantify growth (J−1> 0) or shrinkage (J−1< 0) along
the surface normal direction.
CONSTRUCTION OF THE MEDIAL AXIS
According to the SPHARM parameterization (16), the coordinates
of a given point on the surface is defined by parameters represent-
ing its latitude and longitude (Figure 1A). Varying the latitude
from 0 to 180°at the location of the 0°longitude describes a set
of points that constitute the prime meridian on a hemisphere. In
the same manner, their counterpart points on the opposite hemi-
sphere are obtained by varying the latitude at the 180°longitude.
Averaging these two sets of points in a pair-wise fashion yields
a mean meridian axis, henceforth called MEMAX, represent-
ing a “skeleton” that inherits the point correspondence of the
SPHARM-PDM (Figure 1B) (10). For finer analyses, we further
resampled points on the MEMAX (Figure 1C) using equiangular
subdivisions of the latitude.
To measure shifting, we conducted a group-wise comparison
for each sample point position in the 3D space. To measure bend-
ing, we computed a signed curvature to distinguish convexity from
concavity. Specifically, we first created an open surface mesh whose
boundaries were defined by the prime meridian and that passes
through the MEMAX. We then calculated the signed Gaussian cur-
vature on that surface (the sign is given by the orientation of the
normal vectors), and used the values at the points on the MEMAX.
STATISTICAL ANALYSIS
We compared surface-based point-wise volume and Gaussian cur-
vatures between patient groups and controls using vertex-wise
Student’s t -tests, and position vectors using point-wise Hotelling
T 2-test. In TLE, patients were assessed relative to the epileptogenic
hemisphere (i.e., ipsilateral and contralateral to the seizure focus)
by normalizing vertex-wise volume, curvature, and position vector
using a z-transformation with respect to the distribution of the
corresponding hemisphere of controls. Analyses were corrected
for multiple comparisons using the false discovery rate (FDR)
correction at q< 0.05 (18).
To facilitate the anatomical localization of results, we outlined
hippocampal subfields on the surface template according to a
histological parcellation atlas (19).
RESULTS
GLOBAL VOLUMETRY
Based on 2 SD beyond mean absolute volume and inter-
hemispheric asymmetry of healthy controls, all TLE patients
showed hippocampal atrophy ipsilateral to the seizure focus.
In patients with MCD, volumetric anomalies were present in
51% (45/88) of patients and included both atrophy in 73% (33/45)
and hypertrophy in 27% (12/45). Specifically, in focal cortical dys-
plasia, 34% (10/29) of patients had hippocampal atrophy (ipsilat-
eral to the seizure focus in 80%) and 10% (3/29) had hippocampal
hypertrophy (ipsilateral in 1, bilateral in 1, and contralateral in 1).
In heterotopia, 43% (17/40) of patients had atrophy (unilateral in
11/17, bilateral in 6/17) and 10% (4/40) had hypertrophy (unilat-
eral in 2, bilateral in 2). In polymicrogyria 32% (6/19) of patients
had atrophy (unilateral in 4/6, bilateral in 2/6) and 26% (5/19) had
hypertrophy (unilateral in 4, bilateral in 1).
SURFACE-BASED ANALYSIS
Compared to controls, surface-based analysis in TLE localized
severe ipsilateral atrophy mainly along the rostro-caudal extent
of hippocampal CA1 subfield, with similar effects in patients with
left and right epileptic foci (Figure 2A, FDR< 0.0005). Contralat-
eral atrophy was less severe and limited to small portions of CA1
(FDR< 0.05). We found a significant correlation between dis-
ease duration and areas of atrophy ipsilateral to the seizure focus
(r =−0.4, FDR< 0.05).
Analysis of the curvature revealed bending of the ipsilat-
eral hippocampal tail toward the mid-sagittal plane (FDR< 0.05
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FIGURE 1 | Computation of the mean meridian axis. (A) The SPHARM
function defined by two spherical harmonic coefficients, the latitudes
(yellow) and the longitudes (green), are mapped on the first degree
ellipsoid surface. The prime meridian (blue) defines the longitude when
φ= 0 or pi. After computing spherical basis functions for the hippocampus,
the coefficients are repositioned while preserving shape. (B) The
geometric mean of the upper (s) and lower (sˆ) prime meridians generates
the mean meridian axis (MEMAX, M). (C) Using an equidistant subdivision
of the latitudes, K points are sampled on M. After creating an open
surface mesh (C), whose boundaries are defined by the prime meridians s
and sˆ, the signed Gaussian curvature (κGauss) is computed at each sample
point M(k ) through the surface normal vector n(Ck).
Figure 2B), and the position vectors showed a shift from the
supero-lateral to infero-medial direction with similar effects in
both TLE groups (FDR< 0.05; Figures 2C,D). No position
anomalies were found contralateral to the seizure focus.
In patients with MCD (Figure 3A), we found bilateral symmet-
ric CA1 atrophy in FCD (FDR< 0.05) and HET (FDR< 0.005).
Overall, effects of atrophy were smaller in MCD than in TLE
(FDR< 0.005). In addition, we found bilateral increased volume
corresponding to CA4-DG (FDR< 0.05) in all three MCD groups.
There was no correlation between areas of atrophy and disease
duration.
The analysis of the medial axis detected anomalies in the left
hippocampus only, with flattening (i.e., decrease in curvature)
of the body (FDR< 0.001; Figure 3B) along with a shift from
the lateral to medial direction compared to controls (FDR< 0.05;
Figures 3C,D); the magnitude of these changes were more marked
in HET and PMG than in FCD (FDR< 0.05).
DISCUSSION
Our study showed that morphological anomalies of the hippocam-
pus in TLE and MCD result from a combination of volume and
positional changes. Nevertheless, their nature and distribution
differ between the two cohorts.
METHODOLOGICAL CONSIDERATIONS
Previous surface-based methods attempting to localize hippocam-
pal structural changes have employed thickness-based measure-
ments computed from medial surface or axis models (20–22).
These approaches produce symmetrical measurements on facing
surfaces and tend to mirror findings to the counterpart regions,
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FIGURE 2 | Group comparisons between patients with temporal lobe
epilepsy (TLE) and healthy controls for: (A) Volume; (B) Gaussian
curvature; and (C) position vectors; in (D), the group-wise mean
meridian axis clearly shows the infero-medial shifting of the
hippocampus due to increased curvature in its caudal segment.
Box-and-whisker plots present group differences between each patient
group standardized relative to healthy controls; the solid line indicates the
mean and the dotted lines represent ±1 SD from the mean. Color-scales
refer to FDR-corrected p-values, and L (left) and R (right) to seizure focus
lateralization.
challenging biologically plausible interpretations. Indeed, the sub-
fields are not symmetrically distributed with respect to the geomet-
ric center of the hippocampus. Moreover,histopathological studies
have shown that the magnitude and distribution of neuronal
loss in TLE vary both within and across hippocampal subfields
(23). Alternatively, by computing vertex-wise displacement vec-
tors between a given object and a template, the SPHARM-PDM
approach enables the localization of asymmetrical shape changes
(22). The signed surface normal components of these vectors,
signifying inward or outward deformation, can be interpreted as
volume increase or decrease. A limitation, however, resides in the
fact that this metric may also capture co-occurring positional dif-
ferences, as we have previously shown (8). To obtain an actual
metric of growth or shrinkage, we calculated the Jacobian determi-
nants of the vector fields derived from SPHARM-PDM. We could
thus detect asymmetrically distributed volume anomalies inde-
pendent of positional variations, facilitating our interpretation of
disease-related morphological anomalies.
A previous work has shown that registration procedure used
in SPHARM-PDM may influence spatial metrics such as displace-
ment and local positioning, particularly when dealing with shape
variants (24). Notably, the shape descriptors we implemented,
including Jacobian determinants to assess local volume and signed
curvature to quantify bending, are intrinsically independent of the
alignment process, as shown by our previous validation studies
(8, 10).
BIOLOGICAL CONSIDERATION
In TLE, our analysis localized marked atrophy mainly in the ipsilat-
eral CA1 together with a mild involvement of the other subfields,
a finding in agreement with histopathological data (23). We also
observed small areas of subtle contralateral atrophy confined to
CA1. In MCD, volumetry of the hippocampus has been so far
limited to a single study (25), in which proportions of patients
displaying atrophy across various subgroups were similar to ours.
Here, we refined the characterization of morphological changes
by quantifying subregional anomalies and localized atrophy to
the CA1 subfield, with a highly similar hemispheric distribu-
tion, although the overall extent and effects were smaller than
in TLE. The co-existence of hippocampal atrophy and cortical
developmental disorders, mainly heterotopias, has been defined
as dual pathology (26, 27). The exact nature of this association
is not clearly understood, particularly in patients without elec-
troclinical features pointing to the involvement of the mesial
temporal lobe. Nevertheless, electrophysiological studies target-
ing both the MCD lesion and the hippocampus suggest that the
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FIGURE 3 | Group comparisons between patients with malformations
of cortical development (MCD) and healthy controls for: (A) volume;
(B) Gaussian curvature; and (C) position vectors; in (D), the group-wise
mean meridian axis shows a flattening (i.e., decrease in curvature) of the
body along with a shift from the lateral to medial direction with respect
to controls. Box-and-whisker plots present group differences between each
patient group standardized relative to healthy controls; the solid line indicates
the mean and the dotted lines represent±1 SD from the mean. Color-scales
refer to FDR-corrected p-values; FCD, focal cortical dysplasia; HET,
heterotopia; PMG, polymicrogyria.
latter actively participates to the epileptogenic network and may
not be an innocent bystander (28–31). Indeed, when the hip-
pocampus is surgically resected, histopathology shows evidence
for neuronal loss in CA1 (32). There is also indication for hip-
pocampal hypoplasia as shown in postmortem analysis of human
fetuses with doublecortin deficiency (33). In addition, in animal
models of focal cortical malformations using freeze lesions acute
changes in CA1 inhibitory network (34) have been followed by
atrophy in the chronic phase (35). Nevertheless, the fact that the
hippocampus is not the primary epileptogenic tissue in MCD may
explain the lesser extent and degree of atrophy in these patients
as compared to those with TLE. Further support comes from the
lack of progression of atrophy in our MCD patients as opposed
to TLE.
A striking difference between our two epilepsy cohorts con-
sisted in the presence of bilateral hippocampal hypertrophy, which
was present in about 30% of MCD cases, but absent in TLE. Group
analysis localized this anomaly to the medial-most portion of the
hippocampus corresponding to CA4-DG. Notably, in a detailed
MRI single-case analysis, Montenegro et al. (25) also reported
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enlarged hippocampi in a few patients with lissencephaly and sub-
cortical band heterotopia. A possible explanation may be that den-
tate hypertrophy reflects altered gyral morphology with increased
number of folds (1, 36). Furthermore, there is evidence from ani-
mal models that hypertrophic dentate neurons lead to enlargement
of the hippocampus visible to the naked eye (37). Indeed, in a
mouse model of cortical dysplasia, mutants with a deletion of
the PTEN gene, a tumor suppressor, overactivate the mTOR sig-
naling cascade (37). Normal activity of this pathway is essential
for control of cell growth, proliferation, and survival. Its overex-
pression would induce neuronal hypertrophy and dysmorphism
in the hippocampus and the neocortex through various feedback
loops. Noteworthy, enhanced mTOR signaling was also identified
in hemimegalencephaly (38), and in enlarged dysmorphic neu-
rons and balloon cells of Taylor-type FCD (39) and cortical tubers
(40). These hypotheses remain speculative at this moment and
future histopathological studies are needed to further clarify the
pathophysiology of hippocampal hypertrophy in MCD.
The term malrotation has been coined to describe a set of
positioning features characterized by an abnormal rotation of
the hippocampus around its long axis (vertical orientation) and
a displacement toward the mid-sagittal plane (medial position-
ing), which were originally evaluated on coronal MRI cuts (1, 3,
7, 41), and later quantified through 3D models (7, 8). Notably,
however, a medial shift of the hippocampal centroid may also
result from atrophy at the lateral border corresponding to the
location of CA1, as shown by our current data. In our ear-
lier analyses, we circumvented this confound by using volume
as a nuisance factor (7). Here, position vectors and curvature
derived from the mean meridian axis allowed quantifying intrin-
sic positioning without the need for extra-hippocampal refer-
ences and revealed that in TLE medial positioning results from
bending of the posterior hippocampus ipsilateral to the focus.
In MCD, on the other hand, this anomaly was due to supero-
medial shift of the left hippocampal body, regardless of the
type of the malformation and the lesion side. These findings
suggest that mechanisms underlying medial positioning diverge
between the two epilepsy syndromes. It is temping to propose
that in TLE abnormal positioning may be related to epilepto-
genic process, whereas in MCD hemisphere-specific vulnerabil-
ity to injury may be linked to asymmetric brain development
(42). In this scenario, abnormalities would occur during a time
window of left hemisphere susceptibility when right hemisphere
homologs, due to a more advanced stage of development, are
relatively spared. Alternatively, the location of the MCD may influ-
ence hippocampal morphology through differential connectivity
patterns.
Overall, our group-based results suggest that the differential
patterns of morphological makeup between TLE and MCD may
stem from a complex interplay between genetics, neurogenesis,
and epileptogenesis. The methodological framework we propose
provides the basis for future individual-based analysis and ser-
ial measurements, which may be used as potential clinical and
therapeutic diagnostic biomarkers.
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